Interest of the therapeutic education in patients with type 2 diabetes observing the fast of Ramadan  by Jamoussi, Henda et al.
Alexandria Journal of Medicine (2017) 53, 71–75HO ST E D  BY
Alexandria University Faculty of Medicine
Alexandria Journal of Medicine
http://www.elsevier.com/locate/ajmeInterest of the therapeutic education in patients with
type 2 diabetes observing the fast of Ramadan* Corresponding author at: 15 rue jbel lakkhdher, Tunis, Tunisia. Tel.: +216 52262806.
E-mail address: benothmanr@gmail.com (R. Ben Othman).
Peer review under responsibility of Alexandria University Faculty of Medicine.
http://dx.doi.org/10.1016/j.ajme.2016.01.002
2090-5068  2016 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Henda Jamoussi, Rym Ben Othman *, Salma Chaabouni, Amel Gamoudi,
Olfa Berriche, Feten Mahjoub, Imen Sebai, Chiraz AmroucheNational Institute of Nutrition, Department A, Tunis, TunisiaReceived 15 October 2015; revised 21 December 2015; accepted 11 January 2016
Available online 28 January 2016KEYWORDS
Therapeutic education;
Type 2 diabetes;
Ramadan;
HypoglycemiaAbstract The fast of Ramadan is a dilemma for diabetic patients due to the complexity of the
management of diabetes during this holy month and the multiple risks they face (hypoglycemia,
etc.).
Objectives: Evaluate the impact of a structured protocol of therapeutic education in a sample of
type 2 diabetes, who were authorized by their doctors to fast, on metabolic and anthropometric pro-
files.
Methods: This prospective study was conducted among 54 type 2 diabetic patients (28 men and 26
women) aged 36–65 years, recruited from National Nutrition Institute. Patients were divided into
two groups: the first group (n= 26) received an education session one to two weeks before the
month of Ramadan; the second group (n= 28) did not have appropriate therapeutic education
except therapeutic adjustments. All our diabetic patients benefited from anthropometric measure-
ments, determination of body composition and metabolic assessment (HbA1c, cholesterol, triglyc-
erides, etc.) before and after the month of Ramadan.
Results: The fast was completed without complications in 25 diabetic patients educated group and
22 control patients.
We found that weight loss was greater among educated diabetic patients (1.05 kg) than in controls
(0.58 kg), but without statistical significance. Body composition has not undergone significant
changes in both diabetic groups.
Therapeutic education has led to a decline of 0.27% in HbA1c in the educated group while glycemic
control in diabetic patients uneducated remained stable. Furthermore, we observed a better lipid
profile in diabetic patients educated than those who did not have education.
Conclusion: Our results justify the interest of patient education centered on the month of Ramadan
in all type 2 diabetic patients observing the fast of the holy month. This education should be con-
tinued during Ramadan in order to fulfill this religious rite safely.
 2016 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
72 H. Jamoussi et al.1. Introduction
Fasting during Ramadan is one of the five pillars of Islam. It is
mandatory for all adult Muslims in good health. Diabetic
patients who fast are exposed to several risks related on the
one hand to the period of fasting and on the other to changes
of rhythm and eating habits that characterize the month of
Ramadan i.e. the consumption of meals rich in saturated fats
and carbohydrates with high glycemic index.1 Despite the
ban on the practice of fasting by their doctors, some diabetic
patients insist to fast. According to the study ‘‘EPIDIAR”2,
conducted in 2003 in 13 Islamic countries, 79% of type 2 dia-
betic patients observe the fast of Ramadan. So in order to pre-
vent or reduce the risk of complications in diabetic patients
who fast, recommendations have been drawn1,3,4 and it shows
that therapeutic education focused on the month of Ramadan,
including dietary adjustments and while insisting on glycemic
self-monitoring is crucial. These observations led to carry
out this study, whose main objective is to assess the effective-
ness of a structured therapeutic education protocol before the
month of Ramadan with a sample of type 2 diabetic patients,
identified as low or medium risk of complications, which were
allowed to fast.2. Methods
This is a prospective study which involved 54 type 2 diabetic
patients, recruited two weeks before Ramadan at the service
‘‘A ’’ of the Tunis National Institute of Nutrition, which have
been authorized by their doctors to fast the month of Rama-
dan. In 2013, this month took place from July 9 to August
7. All patients were treated with ADO (oral antidiabetics)
and had an HbA1c 6 9% (glycosylated hemoglobin). Patients
who have experienced severe hypoglycemia in the three months
preceding the month of Ramadan or with macrovascular com-
plications including ischemic heart disease, renal impairment
and pregnant and lactating women were excluded from the- a nutritional education 
session of 30 minutes, 
one or two weeks 
before the start of 
Ramadan.
- It was a collective 
education of at least 10 
patients provided by a 
physician nutritionist 
and a dietician.
G1= 26 patients
54 patien
Figure 1 Designstudy. The recruited patients were divided into two groups
(Fig. 1).
The objective of this education was to enable patients to
acquire knowledge and self-care skills to better manage their
disease during the month of Ramadan, namely:
– Ensure a balanced food intake in both qualitative and
quantitative terms (limiting fatty and fried foods and prod-
ucts with high glycemic index).
– Prevent dehydration by ensuring adequate fluid intake dur-
ing periods of non-fasting.
– Recognize the clinical manifestations of hypoglycemia,
hyperglycemia and learn what to do when they occurred.
– Ensure proper therapeutic compliance by following adapta-
tions of treatment established by the physician.
Emphasize the importance of SMBG, particularly during
the period of fasting, for screening hypoglycemia (<0.7 g/l)
and hyperglycemia (>3 g/l) which are indications to interrupt
fasting.
All patients underwent a search of degenerative complica-
tions and anthropometric measures including the calculation
of body mass index (BMI) and the measure of fat mass by impe-
dance and a complete lipid and glycemic assessment. These
measurements were performed fifteen days to a month before
Ramadan (t1) and were done one or two weeks after the end
of the holy month (t2). Statistical analyzes were performed
using EPI INFO software using the chi-square test (v2) for
the comparison of qualitative variables. As for the comparison
of means, it is based on the Student’s t-test or Kruskal–Wallis if
the conditions are required. A difference is considered statisti-
cally significant if the p value is less than 0.05.
3. Results
The general characteristics of the population are summarized
in Table 1, and both groups were fair for the different param-
eters with a p value that was not significant.-No nutritional education
- Adaptation of the treatment by 
the attending physician prior 
Ramadan
G2= 28 patients
ts
of the study.
Table 1 Sociodemographic, clinical and biological characteristics of the patients.
Characteristics Educated group G1 (n= 26) Non educated group G2 (n= 28)
Age (years) 53 ± 5.3 55 ± 8.6
Sex (n/%) Men 11 (42.3%) 17 (60.71%)
Women 15 (57.7%) 11 (39.29%)
Physical activity (n/%) Sedentary 15 (57.69%) 16 (57.14%)
Moderate 8 (30.76%) 10 (35.71%)
Intensive 3 (11.55%) 2 (7.15%)
IMC (n(%)) IMC< 25 kg/m2 2 (7.7%) 2 (7.14%)
IMCP 25 kg/m2 24 (92.3%) 26 (92.86%)
Diabetes duration (years) 4.27 ± 4 6 ± 3.7
HbA1c (Nbre(%)) (<7%) 8 (31%) 7 (25%)
(P7%) 18 (69%) 21 (75%)
Metformin 12 (46%) 13 (46%)
Sulfonylureas 3 (12%) 2 (7%)
Metformin + sulfonylureas 6 (23%) 10 (36%)
Metformin + DPP IV inhibitorsa 3 (12%) 0 (0%)
Metformin + alpha-glucosidase inhibitor 2 (7%) 3 (11%)
a DPP IV: Dipeptidyl peptidase-4.
Table 2 Evolution of clinical and biological parameters before and after Ramadan.
Educated group G1 (n= 26) Non educated group G2 (n= 28) p
Before Ramadan After Ramadan D Before Ramadan After Ramadan D
Weight (kg) 83.5 ± 12 82.4 ± 13 1.05 82 ± 14 81.1 ± 14 0.58 NS
BMI (kg/m2) <25 67.7 ± 5.4 68.3 ± 8.4 +0.55 54 53.4 0.6 NS
25–29.99 77.5 ± 9.5 76 ± 10 1.24 73.99 ± 6.4 73.8 ± 6.6 0.2 0.004
>30 85.88 ± 9.9 84.82 ± 10.2 1.05 90.39 ± 13.4 89.25 ± 13.3 0.95 NS
Fatty mass (%) 32.5 ± 11 32.2 ± 11 0.386 29 ± 8 28.6 ± 8 0.5 NS
HbA1c (%) 7.47 ± 0.92 7.23 ± 1.0 0.27 7.66 ± 1.15 7.66 ± 1.0 0.004 NS
Triglycerides (mmol/l) 1.38 ± 0.8 1.32 ± 0.54 0.05 1.42 ± 0.58 1.43 ± 0.6 +0.01 NS
Cholesterol total (mmol/l) 4.56 ± 1.09 4.43 ± 0.9 0.13 4.4 ± 1.07 4.28 ± 0.23 0.12 NS
LDL-C (g/l) 1.14 ± 0.32 1.02 ± 0.35 0.144 1.16 ± 0.4 1.07 ± 0.43 0.05 NS
HDL-C (mmol/l) M 1.01 ± 0.18 1.02 ± 0.18 +0.07 0.98 ± 0.17 1.±0.2 +0.02 NS
F 1.12 ± 0.17 1.24 ± 0.25 +0.11 1.03 ± 0.24 1.08 ± 0.22 +0.04 NS
M: men
F: females
D=After Ramadan  before Ramadan
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before and after Ramadan is summarized in Table 2.
During the month of Ramadan, the average blood glucose
levels measured at 11 am were 1.33 ± 0.2 g/l in the educated
group and 1.41 ± 0.4 g/l in the control group. The difference
was not statistically significant and the mean capillary blood
glucose measured two hours after breaking the fast (iftar) in
educated diabetics (1.9 ± 0.5 g/l) was comparable to that of
non-educated group (2 ± 0.6 g/l).
Among our patients, 47 subjects had fasted the whole
month of Ramadan (29 days). Almost all educated diabetics
(96%) fasted all the holy month, while 22% of non educated
diabetics had interrupted their fast. Educated diabetics fasted
for a longer period (28.5 days) than non-educated patients(25.5 days). One patient from each group presented hypo-
glycemia requiring breaking the fast, but no severe hypo-
glycemia was reported. One diabetic enjoyed a therapeutic
education and two uneducated patients had to break their fast
for other reasons such as fatigue and heat. The fasting-related
complications occurring are summarized in Table 3. The fre-
quency of minor hypoglycemia decreased before and during
Ramadan in both groups from 15% to 4% for G1 and 18 to
11% for G2.
4. Discussion
We have not noted an efficiency of our education program on
weight, BMI and fat mass which could be explained by the lack
Table 3 Different complications made during Ramadan.
Educated
group
G1 (n= 26)
Non educated
group
G2 (n= 28)
Total
Minor hypoglycemia
(P1 episode)
2 4 6
Severe hypoglycemia 0 0 0
Hyperglycemia 0 1 1
Dehydration 0 0 0
Ischemic event 0 0 0
Keto-acidosis 0 0 0
Total 2 5 7
74 H. Jamoussi et al.of monitoring during the month of Ramadan, changing both
quantity and quality of food as well as low level of physical
activity. The study READ (Ramadan Education and Aware-
ness in Diabetes)5 which was conducted in England in 2010
with 111 type 2 diabetics treated with ADO showed an average
weight loss of 0.7 kg in patients group that received educa-
tional support vs 0.6 kg in the control group. The study of
Smaoui6and Mustafa7 showed a weight gain. The overweight
type 2 diabetic patients often tend, as in the general popula-
tion, to loose a little weight during Ramadan. Indeed, the
study of northern Algeria8 showed a statistically significant
weight loss in diabetic obese patients during Ramadan. The
authors of this study noted a resumption of weight a month
after Ramadan. A Jordanian study9 showed an average weight
loss of 1.57 kg between the beginning and the end of
Ramadan. This weight loss was only significant in overweight
patients. In a recent study conducted during Ramadan 2014,
the authors found a greater improvement of weight after edu-
cational program.10
The decrease in HbA1C may be secondary to the decrease
in the number of daily meals, which is accompanied by a
reduction in hyperglycemic peaks. In the literature, the results
are controversial as to the change in HbA1c. Indeed, a signif-
icant decrease was noted by some authors6–8,10,11 ranging from
0.11% to 1.94%, a stability of HbA1c has been noted by
others12–14 and some have even noted a deterioration in glyce-
mic control.15,16 In diabetic patients, blood glucose variations
depend on the quantity and quality of diet, possible excessive
consumption during Iftar, the drug compliance and changes
in physical activity.
It appears that the therapeutic education centered on
Ramadan has a beneficial effect on reducing the risk of hypo-
glycemia. Our consistent results with the results of the study
READ5 showed a significant decrease in the number of hypo-
glycemic episodes from 9 to 5 in the group that received
education. The epidemiological study, ‘‘Epidemiology of Dia-
betes and Ramadan” (EPIDIAR), gathering the data from
nearly 12,000 patients with diabetes during Ramadan in 13 dif-
ferent countries2, found an increase in the relative risk of sev-
ere hypoglycemia of 7.5 in type 2 diabetics. It should be noted
that this study did not take into account the severe hypo-
glycemia requiring hospitalization and excluded those that
required the intervention of a third party without hospitaliza-
tion as well as nonsevere hypoglycemia. The incidence of these
is probably underestimated. In type 2 diabetic patients,
increasing the frequency of hypoglycemia during that monthis not systematically recovered. The hypoglycemia could be
favored by a bad adaptation of hypoglycemic therapy and
the jump of meal sehour (the last meal before the beginning
of fast and which often occurs early in the morning). The
observational study of Uysal et al.16 found an increase in
symptomatic hypoglycemia, while other studies17,18 did not
find an increase of hypoglycemia in patients treated with oral
antidiabetic agents or insulin. This divergence of results in
the risk of hypoglycemia, can be explained by the unfolding
of Ramadan in different seasons with a variable duration of
the period of daytime fasting. Thus, the risk of hypoglycemia
can vary from year to year. In addition, hypoglycemia is more
common in diabetics treated with drugs with high hypo-
glycemic power. Finally, the small number of studies dimin-
ishes the power of statistical tests.
As regards the risk of hyperglycemia, EPIDIAR study2
showed a 5-fold increase in the incidence of episodes of severe
hyperglycemia (requiring hospitalization) in patients with type
2 diabetes and a factor of 3 incidence of hyperglycemia epi-
sodes with or without ketoacidosis in type 1 diabetes requiring
hospitalization. The risk of hyperglycemia is attributed to the
reduction of excessive doses of antihyperglycemic drugs (in
order to prevent hypoglycemia) and excessive consumption
of foods with high glycemic index. As for hypoglycemia, the
incidence of non-severe hyperglycemia was not assessed in
the study EPIDIAR. McEwen10 found severe hypoglycemic
events in the control group who did not receive an individual-
ized education.
It appears from all these results that the practice of fasting
of Ramadan by many diabetic patients is not without risk of
complications (hypoglycemia, hyperglycemia, etc.). This find-
ing justifies the imperative of therapeutic management of dia-
betes in Ramadan adapted to allow diabetic patients to fast
with the lowest risk of complications.
Changes in lipid parameters were marked by a stability of
triglyceride levels in both groups of patients. In the literature,
study results are somewhat discordant not to conclude for-
mally the effect of fasting on lipid parameters. Some authors
showed improvement to an antiatherogenic profile.7,16 By con-
trast, some authors found an altered lipid profile in people
with type 2 diabetes. Indeed, the study of Khatib and
Shafagoj9, performed in 44 Jordanians, reported a decrease
in triglycerides during Ramadan with a slight increase in
LDL cholesterol and total cholesterol. The study of Khaled
et al. 8 in 80 Algerian women with type 2 diabetes and obesity
showed a significant increase of approximately 14% of total
cholesterol, 17% of triglycerides and 22% of LDL and a
decrease in HDL-cholesterol. A Tunisian study15 showed no
significant differences between total cholesterol and triglyc-
erides before and at the end of Ramadan, while the rate of
LDL increased and the rate of HDL declined. These changes
disappeared 20 days after the end of fasting. These alterations
were attributed to changes in eating habits during the period of
Ramadan, and more specifically, to the consumption of meals
high in saturated fats.
5. Conclusion
The month of Ramadan is a dilemma for diabetics, who value
fast, while avoiding the risk of complications (severe hypo-
glycemia, hyperglycemia, ketoacidosis, etc.) they may face.
Therapeutic education in patients with type 2 diabetes 75These findings justify the interest of a structured therapeutic
education program adapted to the month of Ramadan which
is characterized by profound changes in lifestyle and eating
habits.
The observation of this holy month of fasting is a real
challenge for the diabetic himself and his doctor. Therapeutic
education should therefore have an important place in the
management of recommendations of diabetes during
Ramadan in order to complete fasting safely. It should be
strengthened among diabetic who choose to fast despite the
medical and religious exemptions. Ramadan is a good time
to acquire knowledge on diabetes management as well as dur-
ing this month throughout the year.
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